Heckmann Corporation (NYSE: HEK)
(“Heckmann”) today announced that the previously announced public offering of its common stock (the “Common Stock”) in an underwritten public offering has priced at $4.40 per share. Heckmann is offering 18,200,000 shares in the offering, an increase of 1,500,000 shares over the anticipated offering amount of 16,700,00 shares. Heckmann has agreed to grant the underwriters a 30-day option to purchase up to an additional 2,730,000 shares to cover over-allotments, if any. Credit Suisse Securities (USA) LLC, Jefferies & Company, Inc. and Roth Capital Partners, LLC are acting as joint book-running managers for this offering.
Heckmann expects to use the net proceeds from this offering to finance a portion of the cash purchase price of its previously-announced acquisition of TFI Holdings, Inc. (“TFI”). If the acquisition of TFI is not completed, Heckmann intends to use the net proceeds from this offering to repay debt under its existing credit facility.
Copies of the prospectus supplement and the accompanying prospectus relating to the offering may be obtained from the offices of Credit Suisse Securities (USA) LLC, Attention: Credit Suisse Prospectus Department, One Madison Avenue, New York, NY 10010 or (800) 221-1037, Jefferies & Company, Inc., 520 Madison Avenue, 12th Floor, New York, NY 10022, (877) 547-6340 or email:
, or Roth Capital Partners, LLC, 888 San Clemente, Newport Beach, CA 92660, (800) 678-9147 or email:
The offering will be made under an effective shelf registration statement filed with the Securities and Exchange Commission (“SEC”). The prospectus supplement (including the accompanying prospectus) will be filed with the SEC and will be available on its website at
This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities, in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. The offering may be made only by means of a prospectus and related prospectus supplement.